Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: The NEOCoast Trial

Dr Myung-Ju Ahn describes the unique design and outcomes of the NEOCoast study that is evaluating immunotherapy regimens in the neoadjuvant and adjuvant settings.

Related Videos
View All
Related Content